
Healthcare Sector

Healthcare.svg)
Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.
May 3, 2023

ETFs.svg)
Mulvihill's XLVE ETF offers exposure to large-cap US healthcare stocks with 25% leverage used for purchasing additional shares to write options, generating income from option premiums while maintaining close to "full" exposure to underlying portfolio stocks.
April 19, 2023

Healthcare.svg)
Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.
April 19, 2023